Herpes Pathology and Product Design
Glycoproteins that exhibit strong immunological responses in patients with herpes infection are targets for diagnostic as well as therapeutic utility. The Herpes Simplex Envelope contains at least 11 glycoproteins that exhibit significant protein and DNA (50%) homology between the two herpes immunological variants, type 1 (HSV-1) and type 2 (HSV-2).
Bio-Rad has taken advantage of some minor antigenic variation in glycoprotein G (also referred as gG) between the two subtypes in order to develop type-specific polypeptide probes for detecting IgG antibodies to HSV-1 and HSV-2. This was achieved by constructing the HSV-1 specific recombinant antigen and HSV-2* specific synthetic peptide conjugated to BSA.
* Bio-Rad BioPlex™ HSV-2 is a patented technology.
